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Summary
 In the present study were conducted the effect of pH (5.5, 6.0 and 6.5) and concentration 
of new synthesized 3-/2-aminophenylimino-(p-toluoyl)/-4-hydroxy-6-(p-tolyl)-2H-pyrane-2-one 
(Schiff base) on decrease the concentration of aflatoxin M1 (AFM1) in raw milk contaminated with 
known concentration of this toxin. Experiments were carried out at temperature of 4 °C during 35 
days. At pH 5.5 Schiff base concentration of 0.1 μmol/L was lessening the concentration of AFM1 
after 35 days by 55 %. However, at pH 6.5 the most effective concentration for lessening of AFM1 
was 0.5 μmol/L. Schiff base was not effective at pH value of 7 or higher. The ability of Schiff base to 
act as antimycotoxigenic agent provides new perspective for possibly using this compound to control 
AFM1 contamination in milk and to extent shelf lives of this food. Detection of toxicity of investi-
gated Schiff base was performed by using the brine shrimp (Artemia salina) larvae as an biological 
indicator to determine their sensitivity to this chemical agent.
 Key words: milk, aflatoxin M1, TLC, Schiff base, Artemia salina
Introduction
 Since the early 1960’s when the outbreak of 
“Turkey X” disease focused a lot of scientific atten-
tion to the recent, then rather neglected area of my-
cotoxins and mycotoxicosis, a wealth of information 
about mycotoxins has been produced. The problem 
of food and feed contamination with mycotoxins is 
of current concern, and has received a great deal of 
attention during the last five decades.
 Exposure to mycotoxins through food is widely 
recognized as human health hazard (Bhat and Vas-
anthy, 1999; Trucksess, 1999; Duraković et 
al., 2008; Nemati et al., 2010; Duraković et al., 
2011a, 2011b). Of all the mycotoxins, aflatoxins 
(AFs) are considered to be the most toxic/carci-
nogenic compounds (IARC, 1993; Manetta et al., 
2005). AFs are highly toxic, mutagenic, teratogenic, 
and carcinogenic compounds that have been impli-
cated as causative agent in human hepatic and ext-
rahepatic carcinogenesis (Dichter, 1984; Groop-
man et al., 1988; Massey et al., 1995, Nemati et 
al., 2010).
 AFs are secondary metabolites produced by 
species of Aspergillus, especially A. flavus and A. 
parasiticus. AFs are dihydrofuran or tetrahydrofuran 
moieties fused to coumarin ring (D’Mello and 
MacDonald, 1997). Of all aflatoxins in naturally 
contaminated substrates, the aflatoxin B1 (AFB1) 
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occurs predominantly, the others being often present 
in small proportion only or even in some cases unde-
tectable.
 AFB1 is biotransformed by hepatic microsomal 
cytochrome P450 to aflatoxin M1 (AFM1) which pos-
sesses 10 times lower carcinogenic potential with re-
spect to parent molecule (Lopez et al., 2003; Unu-
san, 2006). The toxicological concern with AFM1 
arises in principle from its close structure similarity 
to AFB1 (Figure 1) (Duraković, 2007; Duraković 
et al., 2011a).
 When diets contaminated with AFB1 are fed 
to lactating animals, AFM1 is secreted into milk 
(van Egmond and Paulsch, 1986; Škrinjar et 
al., 1995; Galvano et al., 1996a; Tratnik, 1998; 
Rastogi et al., 2004). There was a relationship be-
tween the amount of AFM1 in milk and AFB1 in feed 
consumed by the animals (Wood, 1991; Unusan, 
2006). About 0.3-6.2 % of AFB1 in animal feed is 
transformed to AFM1 in liver and it is secreted into 
milk (Cathey et al., 1994; Jackson and Groop-
man, 1999; Creppy, 2002; Manetta et al., 2005; 
Rastogi et al., 2005). The amount excreted, as a 
percentage of AFB1 in feed, is usually 1-3%, but val-
ues as high as 6 % have been reported (Pittet, 1998; 
Lopez et al., 2003; Diaz et al., 2004).
 Like AFB1, AFM1 is toxic and carcinogenic, al-
though toxicity of AFM1 is somewhat lower than of 
AFB1 (Cole and Cox, 1981; Rastogi et al., 2004; 
Kamkar, 2006). However, AFM1 is great concern 
because of the high consumption of milk and milk 
products by humans, especially children. Interna-
tional Agency for Research on Cancer (IARC) of 
World Health Organization (WHO) included AFB1 
as primary and AFM1 as secondary groups of carcino-
genic compounds (Cathey et al., 1994; Dragacci 
et al., 1995; Unusan, 2006).
 Many countries have carried out various con-
trol and inspection programs of this subject fairly 
concerning about public health for many years. Ac-
cording to the results obtained, maximum aflatoxin 
levels were determined for food and feed. Regula-
tory limits throughout the world are influenced by 
consideration each country’s conditions, and may 
vary from one country to another (van Egmond, 
1989; Stahr et al., 1990; Stoloff et al., 1991; 
Duraković et al., 2011a). The European Com-
munity and Codex Alimentarius prescribe that the 
maximum level of AFM1 in liquid milk and dried or 
processed milk products should not exceed 50 ng/kg 
(Codex Alimentarius Commission, 2001).
 However, according to US Regulation the level 
of AFM1 in milk should not be higher than 500 ng/kg 
(Stoloff et al., 1991). In Austria and Switzerland, 
the maximum level is further reduced to 10 ng/kg 
for infant commodities (FAO, 1997). There are thus 
differences in maximum permissible limit of AFM1 
in milk and dairy products (van Egmond, 1989; 
Unusan, 2006; Nemati et al., 2010; Sefidgar et 
al., 2011). These findings, along with the demon-
stration of occurrence of AFM1 in human and ani-
mal milk, cheese, yoghurt, infant formula and dried 
Figure 1. Chemical structures of aflatoxins B1 and 
M1 (Duraković, 2007; Duraković et 
al., 2011a)
Figure 2. Chemical structure of dehydroacetic acid 
(Coleman and Wolf, 1947; Duraković 
et al., 1994, 2004, 2010b)
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milk, maybe a great significance. This information 
requires that AFM1 has to be given high priority for 
further investigation.
 To prevent of AFM1 formation in milk it is first 
necessary to prevent the growth of AFB1-producing 
fungi. The use of chemical antifungal agents to con-
trol AFB1 production has been intensively investigat-
ed (Diaz et al., 2003; Raman et al., 2003; Verma 
et al., 2004; Zhong et al., 2009; Alpsoy, 2010; 
Duraković et al., 2010b, 2010c). However, the 
use of certain antifungal agents must be viewed with 
reservation, because of ecological problems, which 
may develop later. In 1947, Coleman and Wolf dis-
covered the antimicrobial action of dehydroacetic 
acid (DHA) (Figure 2).
 This chemical compound appears to be effective 
even in the high pH range, but has never acquired 
great significance because of its relatively high toxi-
city. Since the use of DHA as a food preservative is 
not permitted in Europe, in the Laboratory of Organ-
ic Chemistry of the Faculty of Food Technology and 
Biotechnology, University of Zagreb, Croatia, many 
DHA analogues and tetraketones were synthesized 
as potential antimicrobial agents. Some new synthe-
sized analogues of DHA and tetraketones have been 
found to reduce chosen mycotoxins, especially afla-
toxins accumulation (Hasan, 1993; Duraković et 
al., 1994, 1995, 2004, 2006; Prakash et al., 2007; 
Duraković et al., 2010a, 2010b, 2010c, 2011b).
 Methods for the synthesis of these com-
pounds are described by Filipović-Marinić and 
Laćan (1982); Sušnik et al. (1992); Govori et al. 
(2002); Prakash et al. (2007) and Amanullah et 
al. (2011). Preliminary studies in the Laboratory of 
Microbiology of the same Faculty demonstrated that 
several of these new synthesized compounds strong-
ly inhibit the growth of certain species of bacteria, 
yeasts, and moulds, including aflatoxin-producing 
fungi (Duraković et al., 1987, 1989 1994, 2004, 
2006; Duraković, 2007; Duraković et al., 2010a, 
2010b).
 In experiments with toxigenous moulds As-
pergillus flavus, Aspergillus ochraceus, and Fusar-
ium graminearum, the authors (Duraković et al., 
1987, 1989, 1994, 2004, 2006; Duraković, 2007; 
Duraković et al., 2010a, 2010b, 2011b) showed 
that some of the new synthesized DHA analogues 
strongly inhibit growth of these moulds and afla-
toxin B1, ochratoxin A, and vomitoxin accumulation 
in chosen cereals and in liquid media. One of these 
compounds with circumstantial evidence minimal 
inhibitory concentration (MIC) of 0.1 and 0.2 μg/
mL used in these experiments was DHA analogue 
3-/2-aminophenylimino-(p-toluoyl)/-4-hydroxy-6-
(p-tolyl)-2H-pyrane-2-one (Schiff base). Its struc-
ture is presented in Figure 3.
 The objective of this investigation was to assess 
the convenience of treating raw milk with new syn-
thesized analogue of DHA (Schiff base), which was 
tested a priory by a novel in vitro assay for reduction 
of AFM1 concentration in dairy cattle milk, and to 
gain indication of whether effective in vitro can pre-
dict in vivo efficacy.
Materials and methods
AFM1 standard
 Stock solution for AFM1 (Immunolab GmbH, 
Kassel, Germany), was prepared in a methanol/
chloroform mixture (81:19, v/v), 50 μg/mL con-
centration and is kept frozen at -20 °C, when using 
it was diluted in methanol/chloroform (1:1, v/v) at 
proper concentrations (final concentration became 
0.1 μg/mL) (van Egmond, 1989).
Apparatus
 Thin layer plates: Silica gel 60 (Merck, Darm-
stadt, Germany), dimensions 20x20 cm, layer thick-
Figure 3. Chemical structure of Schiff base 
(Duraković et al., 1994, 2010b, 
2011b)
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ness 0.2 mm. Ultraviolet lamp: An ultraviolet lamp 
(UV) lamp with 254 and 364 nm wavelength was 
obtained from Camag.
Primary AFM1 standard solution
 Ten milliliter of chloroform was added to 10 μg 
AFM1 standard bottle that was obtained from Im-
munolab GmbH, Kassel (Germany). Concentration 
in the bottle became 1 μg/mL in chloroform. The 
solution bottle was sealed and wrapped with alumi-
num foil, and stored in cool (4 °C) dry place.
Working standard solution for thin  
layer chromatography (TLC)
 Before preparing working dilutions, it is essen-
tial that 1 μg/mL stock solution, having previously 
been stored at a temperature below 4 °C, is after 
that stored at a temperature of 20 °C, before remov-
ing aliquots of the solution for subsequent dilution. 
By means of pipette, 0.5 mL of the 1 μg/mL AFM1 
stock solution was transferred to a 10 mL graduated 
conical tube and diluted to the 10 mL marked with 
chloroform. This solution contains 0.05 μg/mL of 
AFM1. The solution was well sealed and stored in a 
dark place at room temperature, and was not used 
for longer than 14 days.
Milk
 Raw milk was obtained randomly directly from 
the farms of continental parts of Croatia. The milk 
showed no detectable levels of AFM1 (results not 
presented). The raw milk samples were stored fro-
zen in the dark until used. The milk was dispensed 
in 50 mL aliquots in 350 mL Erlenmeyer flasks. The 
pH was adjusted to 5.5, 6.0, and 6.5 (0.2).
Milk contamination with AFM1 and impact 
of new synthesized analogue
 A solution of AFM1 was prepared by adding to 
a 10 mL centrifuge tube, 1 mL of the AFM1 solution 
(10 mg/mL). Content of the centrifuge tube was 
concentrated to dryness. The tube was then rinsed 
with a 1 % sodium bicarbonate solution; the rinsing 
combined and brought to a final volume of 50 mL, 
which was added to the raw milk used. The pres-
ence of AFM1 was determined in milk before and 
after contamination. For the quantitative analysis of 
AFM1, a series of dilutions were chromatographed 
from the sample extracts to determine the lowest 
dilution, at which AFM1 can still be found.
 From lowest limit of detection of AFM1 (sen-
sitivity on TLC plate) and the dilution factor, the 
appropriate quantity of AFM1 was calculated. Each 
sample was determined in triplicate. The inves-
tigated Schiff base was dissolved in chloroform at 
concentrations of 0.5 and 1.0 mmol/L. The required 
amounts of their solutions were pipetted into test 
Erlenmeyer flasks to give 0.01, 0.05, 0.5, and 1.0 
μmol/L in 50 mL of raw milk. Control flasks and 
duplicate test flasks containing the various concen-
trations of investigated compound, were stored at 
temperature of 4 °C during 35 days.
Methods
 Each sample was analyzed for the determina-
tion of AFM1 concentration every 7 days for a pe-
riod of 35 days by the technique described by van 
Egmond and Wagstaffe (1987) and Škrinjar et 
al. (1995). AFM1 was extracted from 50 mL of raw 
milk samples with 125 mL of chloroform in a labo-
ratory shaker (50 cycles/min.) for one hour at room 
temperature. The extracts were then dried over 
anhydrous sodium sulphate and concentrated in a 
rotary evaporator (50 °C; 1.33 kPa) to a volume of 
5 mL. Evaporated extracts are purified by silica gel 
column chromatography, and each purified extract 
was evaporated to a known volume. The solution 
was evaporated at a temperature of approximately 
50 °C in a current of inert gas, and when the tube 
has cooled, added 100 mL of chloroform using an in-
jection syringe. The contents were mixed by means 
of vortex mixer for 1 min.
 AFM1 is quantified by two-dimensional thin 
layer chromatography. The detection limit of the 
method used is 0.015 μg/L. The average recover-
ies of AFM1 spiked in raw milk at concentrations 
of 0.01, 0.05, and 0.1 μg/L were found to be 83.8, 
86.9, and 90.2 (n=5). The survey results were not 
corrected for recovery. In this method 20 μL of the 
sample extract was obtained, and 3, 6, 12, 24, and 
48 μL of AFM1 working solution (0.05 μg/mL) spot-
ted on plates in the direction of first and second mo-
bile phase, carried out in ether/methanol/water and 
chloroform/acetone/methanol mixture’s, respec-
tively.
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 The amount of AFM1 was estimated visually by 
comparing the fluorescence intensity of the AFM1 
from the raw milk sample, with that of one or more 
amounts of AFM1 standard. The identity of AFM1 
was confirmed by the formation on the plate of a 
derivative using trifluoroacetic acid and comparison 
of the thin layer chromatographic properties of the 
sample derivatives spot and the standard (van Eg-
mond and Wagstaffe, 1987).
 Calculation: The AFM1 level in the sample of 
raw milk expressed is given by the formula:
in which  is the volume, in μL, of the AFM1 stand-
ard used, in interpolation was used the nearest spot 
intensity to the fluorescence intensity of the sam-
ple;  the mass concentration, in μg/mL, of the AFM1 
standard;  the volume, in μL, in which the extract 
was absorbed;  the volume, in μL, of sample used; 
the volume of milk, in mL;  the volume, in mL, of 
the filtrate obtained in extraction steps, and 125 is 
the amount, in mL, of chloroform, used during ex-
traction. The AFM1 levels in milk were expressed as 
μg/L (ppb).
Detection of toxicity of investigated new  
synthesized chemical compound
 The toxicity of new synthesized Schiff base 
was evaluated by using the brine shrimp (Artemia 
salina) larvae as a screening system for the determi-
nation of its sensitivity to some chemical agents. The 
lethality test was performed by using the method of 
Harwing and Scott (1971) and McLaughlin et 
al. (1991). The brine shrimp dehydrated eggs were 
obtained by Hans Brustman, Düsseldorf (Germany) 
and were hatched in artificial seawater (35 g sea salt 
per liter of water), and after an average of 24 h from 
hatching, the shrimp larvae were used for experi-
mental bioassay. For each experiment, 100 to 200 
mg of brine shrimp was placed in a 500 mL Erlen-
meyer flask and shaken as described by Favilla et al. 
(2006) and Duraković et al. (2011a). Hatching can 
occur in less than 24 h at 27 °C.
 Results of 10 parallel experiments showed that 
concentration resulting in 50 % mortality of larvae 
exposed to investigated chemical for 24 h at 30 °C 
was (μg/mL): 28.5 and 27.9, respectively. The re-
sults suggest that the investigated Schiff base had 
a poor toxic effect in relation to A. salina larvae in 
selected parameters of cultivation, and was almost 
eight times less than toxicity of a parent molecule 
(dehydroacetic acid) (Duraković et al., 1986). The 
bioassay with brine shrimp larvae shows consider-
able promise as a screening test under field condi-
tions, especially since very little sophisticated equip-
ment is required.
Determination of reduction index
 The reduction index, which is the ng of AFM1 
reduced per liter of milk per day, was calculated 
according to the formula (Duraković et al., 1994):
Statistical analysis of the data
 AFM1 recoveries from the milk samples were 
performed by using the method recommended by 
AOAC (1995).
 Repeatability and recovery were determined by 
spiking 50 mL of raw milk with toxin standard solu-
tion at the levels 100 to 1000 μg/mL prior to the 
addition of solvent and extraction, and kept at room 
temperature. After 1 h, AFM1 was extracted from 
spiked sample and quantified according to the pro-
tocol (van Egmond and Paulsch, 1986; Bakirci, 
2001). The lowest detection limit of the method 
used is 0.01 ppb. Recovery rates of duplicate experi-
ments were between 83.8 and 90.2, and standard 
Table 1. Percent AFM1 recoveries from spiked raw milk samples
Level spiked (μg/mL) Recovery (%) Average recovery (%) ± SD
0.1 74  96  94  70  117 90.2±6.6
0.5 83  80  79  85   92 83.8±12.8
1.0 76  72  87  93  106 86.9±8.3
SD = standard deviation
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deviation (n=5) was between 6.6 and 12.8 (Table 
1).
 There was no significant difference in the mean 
percent recoveries. The results of toxin investigated 
were not corrected for recovery.
Results and discussion
 The main emphasis of the study was on the 
determination of AFM1 in raw milk after contami-
nation with known concentration of raw milk sam-
ples with this toxin and impact of new synthesized 
analogue of dehydroacetic acid on lessening of AFM1 
concentration in selected parameters of storage in 
safekeeping. The content of AFM1 in the raw milk 
samples before contamination was null.
 Although the use of binding agents to remove or 
reduce of aflatoxins generally is not approved by the 
EU and FDA, respectively, for this purpose, some 
montmorrilonite clay products, some of which are 
known as hydrated sodium calcium aluminosilicate, 
bind AFB1 in vitro and, apparently, in vivo. These 
products, which have been shown to bind AFM1 in 
liquid milk (Harvey et al., 1991), reduce AFM1 in 
milk obtained from cows consuming AFB1-contami-
nated feed, and protect many species from the toxic 
effects of AFB1 (Harvey et al., 1991; Galvano et 
al., 1996b; Ramos et al., 1996; Huwig et al., 2001). 
Activated carbon has also been effective experimen-
tally in reducing milk AFM1 in dairy cows consuming 
AFB1-contaminated feed (Galvano et al., 1996b). 
Commercially available clay products are generally 
recognized as safe by the FDA, when used in feed 
manufacture as flow agents and pellet binders not 
exceeding 2 % on a dry weight basis (Code of Feder-
al Regulations Part 582.2727 and 582.2729) (FDA’s 
CVM, 1999).
 A number of studies have shown that seques-
tering agents such as activated carbons effectively 
bind AFB1 in vitro (Ramos and Hernandez, 1997; 
Galvano et al., 2001; Huwig et al., 2001; Diaz et 
al., 2003). In addition, there have been studies eva-
luating sequestering agents in vivo for their ability 
to protect animals from the effects of dietary AFB1 
and to prevent or reduce AFM1 secretion in milk 
(Phillips et al., 1988; Kimaryamma et al., 1991; 
Galvano et al., 1996b). The best known of these 
are: activated carbon or charcoals, which have been 
variable in effectiveness (Galvano et al., 2001), 
and NovaSil, a clay product often characterized as 
HSCAS, which have been extensively studied for 
its bind to AFB1 and protection a number of species 
from its toxic, growth reducing effects (Ramos et 
al., 1996). NovaSil has also been shown to reduce 
the transmission of AFM1 into milk in dairy cows 
(Harvey et al., 1991).
 Many biological important Schiff bases ligands 
have been reported which possess antifungal, an-
timycotoxigenic, and antibacterial activity (Raman 
et al., 2003; Verma et al., 2004; Janos and Tamas, 
2009; Zhong et al., 2010; Duraković et al., 2011b). 
Dehydroacetic acid (DHA) and its new synthesized 
analogues (Schiff bases, DHT and BrDHT) have also 
been shown to inhibition of growth and accumula-
tion of some mycotoxins as aflatoxins, ochratoxin 
A, F-2 toxin and vomitoxin by moulds of the genera 
Aspergillus and Fusarium (A. flavus, A. parasiticus, 
A. ochraceus and F. graminearum (Duraković et al., 
1989, 2004; Duraković, 2007; Duraković et al., 
2008, 2010a, 2010b, 2010c, 2011a, 2011b).
 A few studies in liquid media have focused on 
Aspergillus species, accumulation, and possible deg-
radation of aflatoxins, but none has evaluated the 
impact of DHA analogues on AFM1, which is con-
tained in milk.
 Few previous studies exist on antimycotoxi-
genicity of dehydroacetic acid and some of its ana-
logues for chosen mycotoxins. Most of the existing 
studies in cereals and in liquid media refer to afla-
toxin biosynthesis and biodegradation, but not any 
or very little information have about impact of DHA 
and its new synthesized analogues to degradation 
or decrease the concentration of AFM1 that is con-
tained in milk (Galvano et al., 1996b; Duraković 
et al., 2004, 2010b, 2011b).
 Our results demonstrated clearly that investiga-
ted analogue (Schiff base) is lessening AFM1 concen-
tration in raw milk in respect to its concentration, 
pH value of milk and stored time. The effect of in-
creasing concentrations of the investigated chemical 
on lessening concentration of AFM1 was evaluated. 
The overall effect of Schiff base at pH 5.5, 6.0, and 
6.5 is shown in Table 2 and in Figures 4a-4c. At pH 
5.5, concentration of AFM1 was lessened by 55 % 
with 0.1 μmol/L of Schiff base and lessened by 28 
% with 0.5 μmol/L of Schiff base. At pH values of 
6.0 and 6.5, Schiff base concentration of 0.1 μmol/L 
and 0.5 μmol/L decrease concentration of AFM1 by 
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31 % and 28 %, respectively, of that in control expe-
riments (Table 2 and Figures 4b and 4c).
 As pH decreased from 6.5 to 5.5, the effect 
of Schiff base increased. Figures 4a-4c represent 
the reduction index curves of AFM1 in respect to 
concentration of Schiff base, pH values of milk and 
deposit time. The results show that reduction index 
significantly decreases as concentration of Schiff 
base increased. At a concentration of Schiff base of 
0.1 μmol/L and pH value of milk of 5.5 and 6.0, the 
reduction index is only 1.5 and 2.0 after 35 days in 
respect to values obtained after 14 days of deposit 
(Figures 4a and 4b).
 It is suggested that specific concentrations of 
Schiff base and pH value of milk are able to lessen-
ing concentration of AFM1. The results reveal that, 
depending on parameters of storage, the investi-
gated Schiff base partly reduces the concentration 
of AFM1. These findings suggest the ability of this 
chemical compound to partly decrease the concen-
tration of this toxin and/or modify AFM1 into com-
pounds with differing chemical characteristics. The 
data obtained indicate that in milk and under certain 
conditions, Schiff base may provide some antiafla-
toxigenic benefit, and thus health protection against 
AFM1 accumulation. In general, although the over-
all efficacy was poor, investigated Schiff base was 
the good candidate to decrease AFM1 concentration 
in raw milk. Further studies should include higher 
treatment, but without compromising organoleptic 
features.
Table 2. Effect of investigated Schiff base on lessening AFM1 concentration in raw milk during the deposit 





Concentration of Schiff base (μmol/L)









5.5 6.0 6.5 5.5 6.0 6.5 5.5 6.0 6.5 5.5 6.0 6.5
14 85.9 88.0 86.0 66.4 79.6 76.5 60.5 75.2 68.5 80.5 73.5 79.0
21 89.0 82.9 98.2 75.8 91.3 90.4 50.7 68.8 86.5 72.0 96.2 80.5
28 102.5 105.4 105.2 96.5 104.8 103.0 56.5 85.9 86.8 109.6 88.5 86.0
35 106.2 112.7 112.5 111.4 96.5 102.8 45.0 72.6 90.5 112.7 84.7 100.5
Figure 4. (a, b and c) Aflatoxin M1 reduction index curves in raw milk containing various Schiff base 
concentrations of 0.01, 0.05, 0.1 and 0.5 μmol/L at pH values: (a) 5.5; (b) 6.0 and (c) 6.5  
during 35 days of deposit
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Sources of analytical difficulty
 TLC method with visual estimation did not 
allow sufficient precision for quantification of 
AFM1, and therefore that results must be used with 
reservation. Standard solutions of AFM1 are a major 
source of error, as has been reported by Horwitz 
(1984).
 Serious errors may also occur because of in-
appropriate handling and storage, e.g. concentration 
by evaporation from opened vials; influence of light, 
heat, or the laboratory atmosphere; poor dilution 
technique, and instability of some solvents. Where 
silica gel cleanup columns are used, particular atten-
tion must be paid to the instructions concerning the 
activity of the silica gel and the purity of the indi-
vidual components used in the washing solvents.
 Small deviation in the water content of the sili-
ca gel or the presence of impurities in some reagents 
and solvents (e.g., the water content in acetic acid) 
may lead to early elution and loss of AFM1 during 
cleanup. The final determination of AFM1 in milk in 
these investigations is generally based on thin layer 
chromatography. In this case, reliable quantification 
requires good separation of the AFM1 spot from 
those coextracted components. It is therefore rec-
ommended that 2-dimensional TLC analysis should 
be used in preference to 1-dimensional TLC analysis 
to obtain reliable separation and quantification.
Conclusions
 Among the contaminants of human’s food, 
the residues of mycotoxins in the dairy products 
constitute a poorly studied problem. Residues of 
the diversified modes of synthesis, the mycotoxins 
have different properties and different rates of milk 
excretion. Only lipophilic compounds, which have 
escaped hydrolysis in the rumen, will undergo this 
phenomenon. Aflatoxin M1, obtained from aflatoxin 
B1, constitutes the principal milk contaminant. Be-
cause the origin of this contamination is known, and 
plans of monitoring are available, an improvement of 
the quality of the products is observed. Many myco-
toxins are identified in food of the cattle, and may 
be responsible for accidents in breeding, without any 
information being available concerning their excre-
tion in milk. Because these compounds may be car-
cinogenic, immunotoxic, poisons for the functions or 
reproduction, a level of zero contamination should 
be required.
 Since a systematic decontamination of food is 
impossible, only an improvement of the quality of 
the raw materials is prove to guarantee the safety 
of the products obtained. The approach needs to be 
based on knowledge about the general mechanisms 
involved in the fungus contamination of food. It 
aims at preventing any risk for the consumer, and 
contribution to improve the image of the products. 
Bioassay may be useful in tracing sources of known 
mycotoxins. However, their use in the surveillance 
of food and foodstuffs for mycotoxins is minor im-
portance.
 In order to broaden the scale of investigations 
on Schiff bases, we have now synthesized, struc-
turally characterized and determined antifungal and 
antimycotoxigenic activity of a number of Schiff 
bases, derived from various aromatic aldehydes and 
aromatic amines, and the results will be published.
Šifova baza: Kemijski agens visokog  
afiniteta za smanjenje koncentracije  
aflatoksina M1 u umjetno kontaminiranom 
sirovom mlijeku
Sažetak
 U navedenom istraživanju određivani su utjecaji 
pH (5,5, 6,0 i 6,5) i koncentracije novosintetizira-
nog spoja 3-/2-aminophenylimino-(p-toluoyl)/4-
hydroxy-6-(p-tolyl)-2H-pyrane-2-one (šifove baze) 
na smanjenje koncentracije aflatoksina M1 (AFM1) 
u sirovom mlijeku, umjetno kontaminiranom s po-
znatom koncentracijom tog toksina. Istraživanja su 
provedena na temperaturi 4 °C u tijeku 35 dana. 
Pri pH 5,5, šifova baza koncentracije 0,1 μmol/L 
rezultirala je smanjenjem koncentracije AFM1 za 55 
% nakon 35 dana. Šifova baza nije bila djelotvorna 
pri pH 7 ili višim. Sposobnost šifove baze da djeluje 
kao antimikotoksigeni agens pruža novu perspektivu 
za moguću upotrebu navedenog kemijskog spoja u 
kontroli kontaminacije mlijeka s AFM1 i produljenju 
trajnosti te namirnice. Određivanje toksičnosti istra-
živane šifove baze provedeno je pomoću larvi račića 
Artemia salina kao biologijskog indikatora za odre-
đivanje njihove osjetljivosti na ovaj kemijski agens. 
 Ključne riječi: mlijeko, aflatoksin M1, 
                             TLC, šifova baza, Artemia salina
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